Pharmacovigilance: Boon for the safety and efficacy of Ayuverdic formulations
Journal name: Journal of Ayurveda and Integrative Medicine
Original article title: Pharmacovigilance: Boon for the safety and efficacy of Ayuvedic formulations
The Journal of Ayurveda and Integrative Medicine (JAIM) is an open-access publication promoting collaboration between Ayurveda, traditional medicine, and biomedicine, publishing research on integrative health sciences
This page does not contain the article itself; See source (below) for actual content.
Original source:
This page only sums up technical details and meta-data hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Anand Chaudhary, Neetu Singh, Neeraj Kumar
Journal of Ayurveda and Integrative Medicine:
(A monthly peer-reviewed publication)
Full text available for: Pharmacovigilance: Boon for the safety and efficacy of Ayuvedic formulations
Year: 2010 | Doi: 10.4103/0975-9476.74427
Copyright (license): CC BY-NC-ND 4.0
Download the PDF file of the original publication
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Pharmacovigilance: Boon for the safety and efficacy of Ayuverdic formulations”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Drug:
Drug refers to any substance used in the diagnosis, treatment, or prevention of disease. In the context of pharmacovigilance, the focus is on ensuring the safety and efficacy of drugs, including traditional medicines like Ayurveda, while monitoring potential adverse reactions that may arise from their use.
2) Medicine:
Medicine is a broad term that encompasses the science and practice of diagnosing, treating, and preventing illness. It includes various systems like conventional medicine and traditional systems such as Ayurveda, which are examined under pharmacovigilance programs to maintain safety and efficacy standards.
3) Ayurveda (Āyurveda, Ayus-veda):
Ayurveda is an ancient Indian system of medicine that emphasizes a holistic approach to health, focusing on balance in body, mind, and spirit. Its growing popularity necessitates vigilant monitoring of adverse drug reactions through established pharmacovigilance programs to ensure patient safety.
4) India:
India is significant as it implemented the National Pharmacovigilance Program for Ayurveda, Siddha, and Unani systems. The program ensures systematic monitoring of adverse drug reactions to enhance the safety and efficacy of Ayurvedic medicines, reflecting India's commitment to integrating traditional medicine with modern health standards.
5) Meeting:
Meeting refers to gatherings that are crucial for discussing and evaluating the progress and effectiveness of the pharmacovigilance program for Ayurvedic medicines. These meetings facilitate the sharing of insights among health professionals and experts to improve ADR monitoring and patient safety.
6) Ayus (Āyus, Ayush):
AYUSH stands for Ayurveda, Yoga, Unani, Siddha, and Homeopathy. It is a government initiative in India aimed at promoting alternative medicine systems. The Department of AYUSH plays a pivotal role in implementing pharmacovigilance programs to ensure the safety of practitioners and patients using these traditional therapies.
7) Life:
Life relates to the Ayurvedic philosophy that considers the natural human life span and the importance of wellness. Traditional Ayurvedic practices aim at promoting a balanced lifestyle that enhances health, longevity, and overall well-being, necessitating careful monitoring of treatments for safety.
8) Pharmacology:
Pharmacology is the study of drugs and their effects on the human body. Within Ayurveda, pharmacology focuses on the properties and interactions of herbal and mineral compounds, essential for understanding safety and optimizing the use of Ayurvedic medicines in health care.
9) Siddha (Siddhā):
Siddha is one of the traditional systems of medicine practiced in India, primarily in Tamil Nadu. Similar to Ayurveda, pharmacovigilance programs extend to Siddha to monitor adverse reactions, ensuring the safety and efficacy of the treatments offered under this ancient medical system.
10) Diet:
Diet is a critical aspect of Ayurvedic treatment, emphasizing the importance of food in healing and wellness. Ayurvedic texts highlight dietary compatibility, and improper diet can lead to adverse reactions, warranting careful observation under pharmacovigilance programs.
11) Teaching:
Teaching refers to the educational aspect of Ayurveda, where practitioners are trained in understanding pharmacovigilance, safety protocols, and the holistic principles of Ayurveda. It is essential for fostering a culture of awareness regarding drug safety among future healthcare providers.
12) Disease:
Disease represents health disorders that Ayurveda aims to treat through holistic methods. The pharmacovigilance program monitors the safety and effects of Ayurvedic medicines in treating various diseases, ensuring effective interventions, and minimizing adverse drug reactions.
13) Science (Scientific):
Scientific approaches in pharmacovigilance validate traditional Ayurvedic practices through research and data analysis, ensuring that safety protocols are evidence-based. This integration fosters trust in Ayurvedic treatments and promotes informed usage among practitioners and patients.
14) Rasa (Rasā, Rasha):
Rasa, in Ayurveda, denotes the taste and therapeutic properties of substances used in treatment. It's an essential concept in understanding how specific formulations interact with the body and why thorough monitoring for adverse reactions is crucial in pharmacovigilance.
15) Food:
Food is heavily emphasized in Ayurveda, not only as nourishment but as a pivotal component of health recovery. It is crucial to monitor food-drug interactions since improper dietary habits may lead to adverse drug reactions.
16) Human life:
Human life is at the core of Ayurvedic practice, which seeks to promote well-being and longevity. The pharmacovigilance program aims to safeguard human life by monitoring the safety of Ayurvedic medicines used for maintaining health and treating diseases.
17) Rasashastra (Rasa-shastra, Rasaśāstra):
Rasa-shastra is the branch of Ayurveda dealing with the preparation and use of medicinal substances, particularly metals and minerals. Understanding this field is crucial for pharmacovigilance, as improper preparation may lead to significant adverse reactions.
18) Education:
Education is vital for training health professionals in the principles of pharmacovigilance in Ayurveda, ensuring they understand the importance of monitoring adverse reactions and safely utilizing traditional medicines in patient care.
19) Shastra (Śāstra):
Shastra refers to classical texts that provide foundational knowledge on Ayurvedic practices. These texts contain guidelines for the preparation and use of medicines, emphasizing the importance of adherence to these teachings to minimize adverse reactions.
20) Gujarat:
Gujarat is home to the Institute of Post Graduate Teaching and Research in Ayurveda (IPGTRA), which plays a significant role in implementing the National Pharmacovigilance Program for Ayurveda, contributing to the monitoring and safety of Ayurvedic medicines.
21) Quality:
Quality pertains to the standards of Ayurvedic medicines, which are critical for ensuring patient safety. The pharmacovigilance program seeks to uphold and enhance the quality of these treatments through rigorous monitoring and reporting of adverse drug reactions.
22) Vaidya:
Vaidya refers to a practitioner of Ayurveda who plays a crucial role in administering treatments. Their awareness and training in pharmacovigilance are essential for accurately reporting adverse drug reactions and ensuring patient safety.
23) Family:
Family connections in Ayurveda emphasize the patient’s social and familial environment as vital components in health and treatment. Understanding these dynamics can help healthcare providers monitor adverse reactions effectively and tailor treatment plans.
24) Reason:
Reason encompasses the rationale behind treatment choices in Ayurveda, including the selection of medicines based on individual patient needs. This understanding is essential for both effective treatment and monitoring for possible adverse reactions.
25) Delhi:
Delhi serves as a central hub for Ayurvedic education and policymaking in India. Important meetings and workshops related to the pharmacovigilance programs take place here, allowing for improved collaboration among government entities and healthcare providers.
26) Table:
Table refers to the structured format used in the article to present key terms and definitions related to pharmacovigilance. This format enhances understanding and clarity of important concepts involved in monitoring Ayurvedic practices.
27) Butter milk (Buttermilk):
Butter milk is mentioned in the context of Ayurvedic dietary incompatibilities. Certain combinations, such as butter milk with fish, may lead to adverse reactions, highlighting the necessity of dietary education and awareness in Ayurvedic treatment.
28) New Delhi:
New Delhi, as the national capital, is significant for hosting government bodies and health departments involved in the implementation of national programs related to pharmacovigilance in Ayurveda, facilitating critical discussions and decision-making.
29) Pharmacological:
Pharmacological aspects in Ayurveda refer to understanding how different Ayurvedic compounds affect bodily functions. Monitoring these effects through pharmacovigilance is critical to ensuring medicines are safe and effective for those who utilize them.
30) Sutrasthana (Sūtrasthāna, Sutra-sthana):
Sutra-sthana is one of the sections of Ayurvedic texts where various principles and guidelines are documented. These texts form the basis for traditional practices and highlight the importance of understanding potential adverse effects.
31) Dravyaguna (Dravyaguṇa, Dravya-guna):
Dravyaguna is a branch of Ayurveda focusing on the properties and functions of medicinal substances. Knowledge in this area is essential for pharmacovigilance to carefully evaluate the safety and side effects of various Ayurvedic formulations.
32) Developing:
Developing refers to the continuous improvements in the pharmacovigilance programs aimed at Ayurvedic medicines. This includes establishing better reporting mechanisms and fostering collaboration among healthcare professionals to enhance drug safety monitoring.
33) Toxicology:
Toxicology studies the adverse effects of substances, including drugs. In the context of Ayurveda, understanding toxicological profiles is necessary to ensure safe use of herbal and mineral preparations within the pharmacovigilance framework.
34) Antibiotic (Antibacterial):
Antibiotics are modern pharmaceuticals widely used to treat bacterial infections. The comparison between antibiotic use and Ayurvedic remedies highlights the importance of establishing safety protocols within pharmacovigilance to evaluate the risks and benefits of each treatment approach.
35) Substance:
Substance refers to any medicinal component used in Ayurvedic treatments. Proper identification and understanding of these substances under pharmacovigilance are vital to ensure safety and monitor adverse reactions effectively.
36) Training:
Training healthcare professionals in pharmacovigilance is crucial to effectively identify and report adverse drug reactions associated with Ayurvedic medicines. Proper education fosters a proactive approach to patient safety within the Ayurvedic practice.
37) Commerce:
Commerce refers to the trade of Ayurvedic medicines, which is increasingly international. Ensuring pharmacovigilance in this context guarantees that Ayurvedic products meet safety standards, benefiting consumers globally.
38) Language:
Language is essential in documenting pharmacovigilance data and communicating findings among practitioners and regulatory bodies. Accurate terminology is vital for understanding and addressing adverse reactions among Ayurvedic medicines.
39) Virodha:
Virodha signifies antagonism in Ayurveda, indicating opposing effects of treatments or dietary combinations. Understanding these concepts is essential within pharmacovigilance to prevent adverse drug reactions that could arise from improper usage.
40) Grahani (Grahaṇī):
Grahani is a term related to digestive health in Ayurveda. Proper understanding of this concept is pivotal in monitoring adverse reactions associated with Ayurvedic medicines that may affect gastrointestinal functions.
41) Kalpana (Kalpanā):
Kalpana refers to the preparation methods of Ayurvedic formulations. Knowledge of these processes is imperative for pharmacovigilance to detect any potential adverse reactions stemming from improper preparation or usage of substances.
42) Account:
Account pertains to the responsibility of reporting and documenting adverse drug reactions in pharmacovigilance. Transparency and thoroughness in these accounts are crucial for maintaining safety standards in Ayurvedic practice.
43) Mineral:
Minerals are often used in Ayurvedic formulations, necessitating careful monitoring to ensure safety. The pharmacovigilance program addresses the potential risks associated with mineral-based treatments and their interactions with other substances.
44) Sthana (Sthāna):
Sthana refers to a site or context within traditional texts denoting certain principles. Recognizing these contexts is important for understanding treatment methodologies and their implications for safety monitoring within Ayurveda.
45) Pathya (Pathyā, Pāṭhya):
Pathya signifies the proper dietary regime advised for health and recovery in Ayurveda. Recognizing specific dietary guidelines is vital in pharmacovigilance to prevent adverse reactions from food-drug interactions.
46) Purity:
Purity emphasizes the importance of ensuring that Ayurvedic medicines are free from contaminants or adulterants. Establishing standards for purity is a critical component of the pharmacovigilance program to ensure patient safety.
47) Nature:
Nature refers to the inherent qualities of medicinal substances in Ayurveda, determining their therapeutic applications. Understanding these natural properties is vital for pharmacovigilance monitoring adverse effects and ensuring safety.
48) Indian:
Indian denotes the cultural and geographic context of Ayurveda. The integration of traditional practices into the broader healthcare framework in India necessitates effective pharmacovigilance to safeguard consumer health.
49) Psyche:
Psyche references the mind and emotions, which are considered integral to treatment in Ayurveda. Understanding the psychological aspects of health is important in pharmacovigilance to fully assess the effects of Ayurvedic medicines on overall well-being.
50) Sutra (Sūtra):
Sutra means a rule or aphorism in Ayurvedic literature that conveys essential principles of treatment. These texts form the basis for understanding practices and potential adverse reactions within the pharmacovigilance framework.
51) Dhatu (Dhātu):
Dhatu refers to the fundamental elements of the body in Ayurveda. Their balance is crucial for health, and pharmacovigilance programs monitor how Ayurvedic treatments influence these elements to avoid adverse reactions.
52) Water:
Water is an important component in Ayurvedic treatments, often used in various preparations. Monitoring the interactions of water with Ayurvedic substances is essential for pharmacovigilance to prevent any adverse reactions due to improper usage.
53) Field:
Field pertains to the practical application of Ayurvedic principles in healthcare. Effective pharmacovigilance requires examining how these principles translate into everyday practices and monitoring their impact on patient safety.
54) House:
House can refer to the environment where Ayurvedic treatments are administered. The setting can influence treatment outcomes and should be considered in pharmacovigilance to ensure safety and efficacy.
55) Earth:
Earth signifies the natural elements that Ayurvedic practices are based upon. Understanding the connection between natural resources and treatment modalities is essential for effective pharmacovigilance monitoring.
56) Deha:
Deha refers to the body in Ayurveda, emphasizing the physical aspect of health. The pharmacovigilance program monitors how treatments impact bodily functions and the potential for adverse reactions.
57) Aha (Ahan, Ahar, Āhār, Āhañ, Āhan, Āha):
Ahar means diet or food in Ayurveda. Understanding the dietary components and their relationships with Ayurvedic treatments is crucial within pharmacovigilance to identify potential adverse reactions.
58) Fish:
Fish is referenced in Ayurvedic dietary guidelines, marking specific incompatibilities with other food items. Attention to these incompatibilities is crucial within pharmacovigilance to prevent adverse reactions associated with dietary habits.
59) Ghi (Ghī, Ghee):
Ghee, a form of clarified butter in Ayurveda, is noted for its numerous health benefits. Understanding its interactions with other dietary elements is essential in pharmacovigilance to ensure safe consumption practices.
60) Milk:
Milk is considered a sacred and staple food item in Ayurveda, commonly used in various formulations. Its relevance in pharmacovigilance lies in understanding potential interactions with other substances that could lead to adverse reactions.
61) Post:
Post signifies the follow-up actions taken after an adverse drug reaction is reported. In the context of pharmacovigilance, this includes repercussions for clinical practice and the necessity for ongoing monitoring to enhance patient safety.